Breakthrough in MS treatment
Monday, January 9, 2017 - 12:01
in Health & Medicine
Three studies have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS.